Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1 plus Cisplatin 3-weekly vs 5-weekly in Advanced Gastric Cancer
NCT00915382Phase 3Completed
- Sponsor
- Asan Medical Center
- Start
- Jan 2009
- Primary completion
- May 2013
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tegafur, Cisplatin micelle injection (HA132) in gastric cancer (GC), sponsored by Asan Medical Center. Started Jan 2009; status: completed.
02
Drugs
tegafurCisplatin micelle injection (HA132)
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00915382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00915382.